Aclaris Therapeutics (8AT) Revenue
Aclaris Therapeutics Revenue
Aclaris Therapeutics had a revenue of 1.63M in the quarter ending Jun 30, 2026, with -18.39%. This bring the company's revenue in the last twelve months to 8.22M, Decreased 1.77%. In the fiscal year ending Dec 31, 2025, Aclaris Therapeutics had annual revenue of 7.83M with -58.19% growth.
- Revenue (ttm)
- 8.22M
- Revenue Growth
- -54.68%
- P/S Ratio
- 66.64
- Revenue/Employee
- EUR 110,225
- Employees
- 71
- Market Cap
- EUR 521.50M
Revenue Chart
Aclaris Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.83M | -10.89M | -58.19% |
| Dec 31, 2024 | 18.72M | -12.53M | -40.09% |
| Dec 31, 2023 | 31.25M | 1.50M | 5.03% |
| Dec 31, 2022 | 29.75M | 22.99M | 340.05% |
| Dec 31, 2021 | 6.76M | 279.00K | 4.30% |
| Dec 31, 2020 | 6.48M | 2.25M | 53.35% |
| Dec 31, 2019 | 4.23M | -5.86M | -58.11% |
| Dec 31, 2018 | 10.09M | 8.41M | 499.58% |
| Dec 31, 2017 | 1.68M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.